Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The potential impact of pharmacogenetic testing on medication adherence.

Literature DB >> 23999596

The potential impact of pharmacogenetic testing on medication adherence.

Abstract

Poor medication adherence is a well-known problem, particularly in patients with chronic conditions, and is associated with significant morbidity, mortality and health-care costs. Multi-faceted and personalized interventions have shown the greatest success. Pharmacogenetic (PGx) testing may serve as another tool to boost patients' confidence in the safety and efficacy of prescribed medications. Here, we consider the potential impact (positively or negatively) of PGx testing on medication-taking behavior.

Entities: Chemical Disease Gene Species

Mesh：

Year: 2013 PMID： 23999596 PMCID： PMC3969027 DOI： 10.1038/tpj.2013.33

Source DB: PubMed Journal: Pharmacogenomics J ISSN： 1470-269X Impact factor: 3.550

27 in total

Review 1. Adherence to medication.

Authors: Lars Osterberg; Terrence Blaschke
Journal: N Engl J Med Date: 2005-08-04 Impact factor: 91.245

Review 2. Personalized medicine: is it a pharmacogenetic mirage?

Authors: Rashmi R Shah; Devron R Shah
Journal: Br J Clin Pharmacol Date: 2012-10 Impact factor: 4.335

Review 3. Medication adherence: a call for action.

Authors: Hayden B Bosworth; Bradi B Granger; Phil Mendys; Ralph Brindis; Rebecca Burkholder; Susan M Czajkowski; Jodi G Daniel; Inger Ekman; Michael Ho; Mimi Johnson; Stephen E Kimmel; Larry Z Liu; John Musaus; William H Shrank; Elizabeth Whalley Buono; Karen Weiss; Christopher B Granger
Journal: Am Heart J Date: 2011-09 Impact factor: 4.749

4. A qualitative study of medication-taking behaviour in primary care.

Authors: J Dowell; H Hudson
Journal: Fam Pract Date: 1997-10 Impact factor: 2.267

5. Statistical numeracy for health: a cross-cultural comparison with probabilistic national samples.

Authors: Mirta Galesic; Rocio Garcia-Retamero
Journal: Arch Intern Med Date: 2010-03-08

6. Development and validation of motivational messages to improve prescription medication adherence for patients with chronic health problems.

Authors: Gary L Kreps; Melinda M Villagran; Xiaoquan Zhao; Colleen A McHorney; Christy Ledford; Melinda Weathers; Brian Keefe
Journal: Patient Educ Couns Date: 2011-05-24

7. Impact of medication adherence on hospitalization risk and healthcare cost.

Authors: Michael C Sokol; Kimberly A McGuigan; Robert R Verbrugge; Robert S Epstein
Journal: Med Care Date: 2005-06 Impact factor: 2.983

8. Primary medication non-adherence: analysis of 195,930 electronic prescriptions.

Authors: Michael A Fischer; Margaret R Stedman; Joyce Lii; Christine Vogeli; William H Shrank; M Alan Brookhart; Joel S Weissman
Journal: J Gen Intern Med Date: 2010-02-04 Impact factor: 5.128

9. Providing patients with pharmacogenetic test results affects adherence to statin therapy: results of the Additional KIF6 Risk Offers Better Adherence to Statins (AKROBATS) trial.

Authors: S L Charland; B C Agatep; V Herrera; B Schrader; F W Frueh; M Ryvkin; J Shabbeer; J J Devlin; H R Superko; E J Stanek
Journal: Pharmacogenomics J Date: 2013-08-27 Impact factor: 3.550

Review 10. Interventions for improving adherence to treatment in patients with high blood pressure in ambulatory settings.

Authors: K Schroeder; T Fahey; S Ebrahim
Journal: Cochrane Database Syst Rev Date: 2004

25 in total

1. Pharmacogenetic tests yield bonus benefit: better drug adherence.

Authors: Elie Dolgin
Journal: Nat Med Date: 2013-11 Impact factor: 53.440

Review 2. Striking a balance in communicating pharmacogenetic test results: promoting comprehension and minimizing adverse psychological and behavioral response.

Authors: Susanne B Haga; Rachel Mills; Hayden Bosworth
Journal: Patient Educ Couns Date: 2014-06-21

Review 3. Challenges to integrating pharmacogenetic testing into medication therapy management.

Authors: Susanne B Haga; Nancy M Allen LaPointe; Jivan Moaddeb
Journal: J Manag Care Spec Pharm Date: 2015-04

4. Pilot study of pharmacist-assisted delivery of pharmacogenetic testing in a primary care setting.

Authors: Susanne B Haga; Nancy M Allen LaPointe; Alex Cho; Shelby D Reed; Rachel Mills; Jivan Moaddeb; Geoffrey S Ginsburg
Journal: Pharmacogenomics Date: 2014-09 Impact factor: 2.533

5. Pharmacogenomics in diverse practice settings: implementation beyond major metropolitan areas.

Authors: Elizabeth H Dorfman; Susan Brown Trinidad; Chelsea T Morales; Kevin Howlett; Wylie Burke; Erica L Woodahl
Journal: Pharmacogenomics Date: 2015 Impact factor: 2.533

6. Nurses' communication of pharmacogenetic test results as part of discharge care.

Authors: Susanne B Haga; Rachel Mills
Journal: Pharmacogenomics Date: 2015 Impact factor: 2.533

Review 7. Health Disparities of Cardiometabolic Disorders Among Filipino Americans: Implications for Health Equity and Community-Based Genetic Research.

Authors: Gerald Coronado; Jacqueline Chio-Lauri; Rosheanne Dela Cruz; Youssef M Roman
Journal: J Racial Ethn Health Disparities Date: 2021-11-26

8. Pharmacogenomic-Based Decision Support to Predict Adherence to Medications.

Authors: Carlton Christian; Brittany A Borden; Keith Danahey; Kiang-Teck J Yeo; Xander M R van Wijk; Mark J Ratain; Peter H O'Donnell
Journal: Clin Pharmacol Ther Date: 2020-05-25 Impact factor: 6.875

9. Clinical pharmacogenomics: patient perspectives of pharmacogenomic testing and the incidence of actionable test results in a chronic disease cohort.

Authors: Chandrama Mukherjee; Kevin M Sweet; Jasmine A Luzum; Mahmoud Abdel-Rasoul; Michael F Christman; Joseph P Kitzmiller
Journal: Per Med Date: 2017-09-01 Impact factor: 2.512

10. Metformin pharmacogenomics: current status and future directions.

Authors: Aaron C Pawlyk; Kathleen M Giacomini; Catherine McKeon; Alan R Shuldiner; Jose C Florez
Journal: Diabetes Date: 2014-08 Impact factor: 9.461